Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Cue Biopharma
CUE
$113M
| $138K | ﹤0.01% |
1,993
-3,174
| -61% | -$310K |
|
3177
First Guaranty Bancshares
FGBI
$158M
| $137K | ﹤0.01% |
12,483
-16,800
| -57% | -$197K |
|
3178
FinWise Bancorp
FINW
$192M
| $137K | ﹤0.01% |
15,900
+1,600
| +11% | +$15K |
|
|
NAK
3179
Northern Dynasty Minerals
NAK
$947M
| $137K | ﹤0.01% |
420,880
-879,890
| -68% | -$249K |
|
3180
Aemetis
AMTX
$108M
| $136K | ﹤0.01% |
+32,700
| New | +$200K |
|
|
VIVS
3181
VivoSim Labs
VIVS
$1.26M
| $136K | ﹤0.01% |
9,099
-1,788
| -16% | -$31.6K |
|
3182
CervoMed
CRVO
$26M
| $135K | ﹤0.01% |
29,233
+2,360
| +9% | +$11.9K |
|
3183
Mexco Energy
MXC
$18.8M
| $135K | ﹤0.01% |
10,400
+200
| +2% | +$2.54K |
|
|
VINC
3184
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $134K | ﹤0.01% |
6,645
-1,310
| -16% | -$25.4K |
|
|
LUXH
3185
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
| $134K | ﹤0.01% |
411
+225
| +121% | +$50.4K |
|
|
GRCL
3186
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $134K | ﹤0.01% |
46,600
-2,500
| -5% | -$9.14K |
|
3187
Arts-Way Manufacturing Co
ARTW
$11.4M
| $133K | ﹤0.01% |
56,674
+1,000
| +2% | +$2.56K |
|
3188
United States Antimony
UAMY
$947M
| $133K | ﹤0.01% |
361,322
+31,622
| +10% | +$12.6K |
|
3189
OptimumBank Holdings
OPHC
$107M
| $132K | ﹤0.01% |
41,500
+200
| +0.5% | +$616 |
|
|
AGTI
3190
DELISTED
Agiliti Inc
AGTI
| $132K | ﹤0.01% |
+20,313
| New | +$246K |
|
3191
Sportsman's Warehouse
SPWH
$46M
| $131K | ﹤0.01% |
+29,100
| New | +$150K |
|
3192
Traws Pharma
TRAW
$8.5M
| $131K | ﹤0.01% |
7,348
-2,039
| -22% | -$46.5K |
|
3193
Abeona Therapeutics
ABEO
$384M
| $130K | ﹤0.01% |
30,837
-2,700
| -8% | -$10.2K |
|
3194
Lantern Pharma
LTRN
$35.6M
| $130K | ﹤0.01% |
38,100
-6,800
| -15% | -$30.9K |
|
3195
Magyar Bancorp
MGYR
$129M
| $130K | ﹤0.01% |
12,700
-700
| -5% | -$7.55K |
|
3196
Dogness International Corp
DOGZ
$13.6M
| $129K | ﹤0.01% |
13,710
-220
| -2% | -$2.92K |
|
|
OBE
3197
Obsidian Energy
OBE
$618M
| $129K | ﹤0.01% |
15,700
-23,072
| -60% | -$161K |
|
3198
Bitdeer Technologies
BTDR
$2.75B
| $128K | ﹤0.01% |
+13,300
| New | +$158K |
|
3199
SCYNEXIS
SCYX
$52.3M
| $124K | ﹤0.01% |
6,780
-17,043
| -72% | -$407K |
|
|
MAGN
3200
Magnera Corp
MAGN
$490M
| $124K | ﹤0.01% |
4,762
-6,830
| -59% | -$227K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.